Ignite Creation Date:
2024-05-06 @ 6:02 PM
Last Modification Date:
2024-10-26 @ 2:40 PM
Study NCT ID:
NCT05529342
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2022-12-02
First Post:
2022-09-02
Brief Title:
Long-term Follow-up of Study Participant Treated With Lentiviral-Based Genetically Modified Autologous Cell Product AGT103-T
Sponsor:
American Gene Technologies International Inc
Organization:
American Gene Technologies International Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-29
Start Date Type:
ACTUAL
Primary Completion Date:
2038-05-23
Primary Completion Date Type:
ESTIMATED
Completion Date:
2038-09-29
Completion Date Type:
ESTIMATED
First Submit Date:
2022-09-02
First Submit QC Date:
September 2 2022
Study First Post Date:
2022-09-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-30
Last Update Post Date:
2022-12-02
Last Update Post Date Type:
ACTUAL